Journal
ACS CHEMICAL NEUROSCIENCE
Volume 7, Issue 1, Pages 15-20Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acschemneuro.5b00234
Keywords
Photopharmacology; retinal degeneration; AMPA receptors; photochromic ligand; ATA
Funding
- European Research Council (ERC) [268795]
Ask authors/readers for more resources
Retinal degenerative diseases can have many possible causes and are currently difficult to treat. As an alternative to therapies that require genetic manipulation or the implantation of electronic devices, photopharmacology has emerged as a viable approach to restore visual responses. Here, we present a new photopharmacological strategy that relies on a photoswitchable excitatory amino acid, ATA. This freely diffusible molecule selectively activates AMPA receptors in a light-dependent fashion. It primarily acts on amacrine and retinal ganglion cells, although a minor effect on bipolar cells has been observed. As such, it complements previous pharmacological approaches based on photochromic channel blockers and increases the potential of photopharmacology in vision restoration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available